BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 7:26:00 PM | Browse: 1006 | Download: 1056
|
Received |
|
2013-10-09 08:28 |
|
Peer-Review Started |
|
2013-10-09 10:51 |
|
To Make the First Decision |
|
2013-12-26 11:09 |
|
Return for Revision |
|
2013-12-26 15:19 |
|
Revised |
|
2014-01-27 23:25 |
|
Second Decision |
|
2014-03-13 13:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-03-13 16:36 |
|
Articles in Press |
|
2014-05-23 11:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-03-21 17:30 |
|
Typeset the Manuscript |
|
2014-06-14 20:04 |
|
Publish the Manuscript Online |
|
2014-07-14 17:39 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
|
Manuscript Source |
Invited Manuscript |
All Author List |
Stina Nordh, Daniel Ansari and Roland Andersson |
Funding Agency and Grant Number |
|
Corresponding Author |
Roland Andersson, MD, PhD, Department of Surgery, Clinical Sciences Lund, Lund University and Sk?ne University Hospital, Paradisgatan 2, SE-221 85 Lund, Sweden. roland.andersson@med.lu.se |
Key Words |
Pancreatic cancer; Gemcitabine; hENT1; Predictive; Survival |
Core Tip |
Human equilibrative nucleoside transporter 1 is a predictive marker for pancreatic cancer patients treated with gemcitabine. |
Publish Date |
2014-07-14 17:39 |
Citation |
Nordh S, Ansari D, Andersson R. hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review. World J Gastroenterol 2014; 20(26): 8482-8490 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i26/8482.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i26.8482 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345